ANI Pharmaceuticals
ANIP
126 hedge funds and large institutions have $434M invested in ANI Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 13 closing their positions.
307% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $3M
192% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 13
37% more capital invested
Capital invested by funds: $317M → $434M (+$117M)
31% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 32
25% more funds holding
Funds holding: 101 → 126 (+25)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$18.4M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$17.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$13.6M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$8.43M |
| 5 |
Millennium Management
New York
|
+$7.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$5.74M |
| 2 |
FIM
Foresters Investment Management
New York
|
-$5.2M |
| 3 |
MOACM
Mutual of America Capital Management
New York
|
-$4.25M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.9M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$3.12M |
ANIP Hedge Fund Activity: Q1 2015 in Review
126 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2015, worth a combined $434M — up 37% from $317M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ANIP positions and 13 closed out — a net gain of 25 holders — while 42 added to existing stakes and 32 trimmed.
The largest buyer was State Street, adding an estimated $18.4M. The largest seller was Wells Fargo, cutting an estimated $5.74M.
- 126 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2015, up from 101 in Q4 2014.
- Funds reported $434M of ANI Pharmaceuticals stock for Q1 2015, up 37% quarter-over-quarter.
- 38 funds opened new ANI Pharmaceuticals positions in Q1 2015 and 13 closed out, a net change of +25 holders.
- The largest ANI Pharmaceuticals buyer in Q1 2015 was State Street, an estimated $18.4M added.
- The largest ANI Pharmaceuticals seller in Q1 2015 was Wells Fargo, an estimated $5.74M sold.
Based on aggregated 13F filings for Q1 2015.